Based on such experimental results, the authors hypothesized that recovery from end-stage liver disease was not dependent on HPCs amplification and differentiation, and overexpression of HNF4α did not show a propensity effect on HPCs differentiation toward the hepatocyte lineage. The gene discussed is HNF4A; the disease is End Stage Liver Disease.